2026-04-17T16:03:32Zhttps://repositorio.fucsalud.edu.co/server/oai/request

oai:repositorio.fucsalud.edu.co:001/25372022-02-21T20:38:29Zcom_001_33col_001_34

Casas, Claudia Patricia Reyes, Jheremy Solano, Maria Helena Espinosa, Daniel Abello, Virginia 2015-03-01 00:00:00 2022-02-21T20:38:29Z 2015-03-01 2015-03-01 00:00:00 2022-02-21T20:38:29Z Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud Fundación Universitaria de Ciencias de la Salud FUCS - 0 info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2 https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/648 hemofilia cirugía desenlaces hemophilia surgery outcomes Criterios de respuesta para definir éxito en la terapia de pacientes hemofílicos llevados a cirugía: Revisión ampliada de la literatura (RAL) Response criteria to define success in the therapy of hemophilic patients undergoing surgery: Extended literature review (RAL) application/pdf Artículo de revista Journal article http://purl.org/coar/resource_type/c_6501 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Text http://purl.org/coar/version/c_970fb48d4fbd8a85 10.31260/RepertMedCir.v24.n1.2015.648 0121-7372 https://repositorio.fucsalud.edu.co/handle/001/2537 2462-991X https://doi.org/10.31260/RepertMedCir.v24.n1.2015.648 spa Aledort LM. History of haemophilia. Haemophilia. 2007 Dec;13 Suppl 5:1-2. Oldenburg J, Dolan G, Lemm G. Haemophilia care then, now and in the future. Haemophilia. 2009 Jan; 15 Suppl 1:2-7. Stachnik J. Hemophilia: Etiology, complications, and current options in management. Clin Pharm. 2010: 45. Wong T, Recht M. Current options and new developments in the treatment of haemophilia. Drugs. 2011 Feb; 71(3):305-20. Lee CA. The best of times, the worst of times: a story of haemophilia. Clin Med. 2009 Oct; 9(5):453-8. Evatt BL. The tragic history of AIDS in the hemophilia population. 1982-1984. J Thromb Haemost. 2006 Nov; 4(11):2295-301. Mannucci PM. AIDS, hepatitis and hemophilia in the 1980s: memoirs from an insider. J Thromb Haemost. 2003 Oct;1(10):2065-9 Chorba TL, Holman RC, Strine TW, Clarke MJ, Evatt BL. Changes in longevity and causes of death among persons with hemophilia A. Am J Hematol. 1994 Feb;45(2):112-21 Mannucci PM, Tuddenham EG. The hemophilias from royal genes to gene therapy. N Engl J Med. 2001 Jun 7; 344(23):1773-9. Rodriguez-Merchan EC. Local fibrin glue and chitosan-based dressings in haemophilia surgery. Blood Coagul Fibrinolysis. 2012 Sep; 23(6):473-6. Aznar JA, Marco A, Jiménez-Yuste V, et al. Is on-demand treatment effective in patients with severe haemophilia?. Haemophilia. 2012 Sep;18(5):738-42. Eckhardt CL, Mauser-Bunschoten EP, Peters M, Leebeek FW, et al. Inhibitor incidence after intensive FVIII replacement for surgery in mild and moderate haemophilia A: a prospective national study in the Netherlands. Br J Haematol. 2012 Jun; 157(6):747-52. Batorova A, Holme P, Gringeri A, Richards M, Hermans C, Altisent C, et al. Continuous infusion in haemophilia: current practice in Europe. Haemophilia. 2012 Sep; 18(5):753-9. Pérez-Garrido R, Alonso N, Jiménez-Yuste V et al. Efficacy of factor IX Grifols(®) in surgery: experience of an international multicenter retrospective study. Haemophilia. 2012 Sep; 18(5):e372-3. Holmström M, Tran HT, Holme PA. Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A--a two-centre experience. Haemophilia. 2012 Jul; 18(4):544-9. Coppola A, Franchini M, Makris M, Santagostino E, et al. Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies. Haemophilia. 2012 May;18(3):e173-87. Berntorp E, Astermark J, Baghaei F, et al. Treatment of haemophilia A and B and von Willebrand’s disease: summary and conclusions of a systematic review as part of a Swedish health-technology assessment. Haemophilia. 2012 Mar; 18(2):158-65. Zülfikar B, Aydogan G, Salcioglu Z, Oner AF, Kavakli K, et al. Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey. Haemophilia. 2012 May; 18(3):383-91. Eckhardt CL, van der Bom JG, van der Naald M, et al. Surgery and inhibitor development in hemophilia A: a systematic review. J Thromb Haemost. 2011 Oct; 9(10):1948-58. Rossi M, Jayaram R, Sayeed R. Do patients with haemophilia undergoing cardiac surgery have good surgical outcomes?. Interact Cardiovasc Thorac Surg. 2011 Sep; 13(3):320-31. Mauser-Bunschoten EP, Kleine Budde I, Lopaciuk S, Koopman MM, et al. An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies. Haemophilia. 2011 May; 17(3):439-45. Oldenburg J, Goudemand J, Valentino L, et al. Postauthorization safety surveillance of ADVATE [antihaemophilic factor (recombinant), plasma/albumin-free method] demonstrates efficacy, safety and low-risk for immunogenicity in routine clinical practice. Haemophilia. 2010 Nov; 16(6):866-77. Windyga J, Rusen L, Gruppo R, et al. BDDrFVIII (Moroctocog alfa [AF-CC]) for surgical haemostasis in patients with haemophilia A: results of a pivotal study. Haemophilia. 2010 Sep 1; 16(5):731-9. Martinowitz U, Luboshitz J, Bashari D, et al. Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia. Haemophilia. 2009 May; 15(3):676-85. Giangrande PL, Wilde JT, Madan B, et al. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors. Haemophilia. 2009 Mar; 15(2):501-8. Négrier C, Shapiro A, Berntorp E, et al. Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: efficacy and safety of Advate in previously treated patients. Thromb Haemost. 2008 Aug; 100(2):217-23. Schwarz KB, Zellos A, Stamato L, et al. Percutaneous liver biopsy in hemophiliac children with chronic hepatitis C virus infection. J Pediatr Gastroenterol Nutr. 2008 Apr; 46(4):423-8. Miles J, Rodríguez-Merchán EC, Goddard NJ. The impact of haemophilia on the success of total hip arthroplasty. Haemophilia. 2008 Jan; 14(1):81-4. Correa ME, Annicchino-Bizzacchi JM, Jorge J Jr, et al. Clinical impact of oral health indexes in dental extraction of hemophilic patients. J Oral Maxillofac Surg. 2006 May; 64(5):785-8. Franchini M, Rossetti G, Tagliaferri A, et al. Dental procedures in adult patients with hereditary bleeding disorders: 10 years experience in three Italian Hemophilia Centers. Haemophilia. 2005 Sep; 11(5):504-9. Türkmen C, Zülflkar B, Taşer O, et al. Radiosynovectomy in hemophilic synovitis: correlation of therapeutic response and blood-pool changes. Cancer Biother Radiopharm. 2005 Jun; 20(3):363-70. Soroa VE, del Huerto Velázquez Espeche M, Giannone C, et al. Effects of radiosynovectomy with p-32 colloid therapy in hemophilia and rheumatoid arthritis. Cancer Biother Radiopharm. 2005 Jun; 20(3):344-8. Lee AP, Boyle CA, Savidge GF, Fiske J. Effectiveness in controlling haemorrhage after dental scaling in people with haemophilia by using tranexamic acid mouthwash. Br Dent J. 2005 Jan 8; 198(1):33-8. Karaman MI, Zulfikar B, Caskurlu T, Ergenekon E. Circumcision in hemophilia: a cost-effective method using a novel device. J Pediatr Surg. 2004 Oct; 39(10):1562-4. Stieltjes N, Altisent C, Auerswald G, et al. Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience. Haemophilia. 2004 Sep; 10(5):452-8. Rodriguez-Merchan EC, Wiedel JD, Wallny T, et al. Elective orthopaedic surgery for inhibitor patients. Haemophilia. 2003 Sep; 9(5):625-31. Hoots WK, Leissinger C, Stabler S, et al. Continuous intravenous infusion of a plasma-derived factor IX concentrate (Mononine) in haemophilia B. Haemophilia. 2003 Mar; 9(2):164-72. Giangrande PL; KOGENATE Bayer Study Group. Safety and efficacy of KOGENATE Bayer in previously untreated patients (PUPs) and minimally treated patients (MTPs). Haemophilia. 2002 Mar; 8 Suppl 2:19-22. Ragni MV, Pasi KJ, White GC, Giangrande PL, et al. Use of recombinant factor IX in subjects with haemophilia B undergoing surgery. Haemophilia. 2002 Mar; 8(2):91-7. Smith OP. Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high-responding inhibitors. Pathophysiol Haemost Thromb. 2002; 32 Suppl 1:22-5. Scharrer I, Brackmann HH, Sultan Y, et al. Efficacy of a sucrose-formulated recombinant factor VIII used for 22 surgical procedures in patients with severe haemophilia A. Haemophilia. 2000 Nov; 6(6):614-8. MacKinlay N, Taper J, Renisson F, et al. Cardiac surgery and catheterization in patients with haemophilia. Haemophilia. 2000 Mar;6(2):84-8. Bollard CM, Teague LR, Berry EW, Ockelford PA. The use of central venous catheters (portacaths) in children with haemophilia. Haemophilia. 2000 Mar;6(2):66-70. Tagariello G, Davoli PG, Gajo GB, et al. Safety and efficacy of high-purity concentrates in haemophiliac patients undergoing surgery by continuous infusion. Haemophilia. 1999 Nov; 5(6):426-30. Scharrer I. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency. Haemophilia. 1999 Jul; 5(4):253-9. Rochat C, McFadyen ML, Schwyzer R, et al. Continuous infusion of intermediate-purity factor VIII in haemophilia A patients undergoing elective surgery. Haemophilia. 1999 May; 5(3):181-6. Shapiro AD, Gilchrist GS, Hoots WK, et al. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost. 1998 Nov; 80(5):773-8. Négrier C, Menart C, Attali O, et al. Evaluation of coagulation equilibrium at baseline and during factor VIII and factor IX replacement in haemophiliacs. Blood Coagul Fibrinolysis. 1998 Mar; 9 Suppl 1:S135-41. Santagostino E, Gringeri A, Muça-Perja M, et al. A prospective clinical trial of implantable central venous access in children with haemophilia. Br J Haematol. 1998 Sep; 102(5):1224-8. F Gordon, P Mistry, C Sabin, and C Lee. Outcome of orthotopic liver transplantation in patients with haemophilia. Gut. May 1998; 42(5): 744-9. Djulbegovic B, Marasa M, Pesto A, et al. Safety and efficacy of purified factor IX concentrate and antifibrinolytic agents for dental extractions in hemophilia B. Am J Hematol. 1996 Feb; 51(2):168-70. Waly NG. Local antifibrinolytic treatment with tranexamic acid in hemophilic children undergoing dental extractions. Egypt Dent J. 1995 Jan;41(1):961-8. Pearce MS, Smith MA, Savidge GF. Supramalleolar tibial osteotomy for haemophilic arthropathy of the ankle. J Bone Joint Surg Br. 1994 Nov; 76(6):947-50. Santagostino E, Mannucci PM, Gringeri A, et al. Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery. Thromb Haemost. 1994 Jun; 71(6):737-40. Goldsmith JC, Kasper CK, Blatt PM, et al. Coagulation factor IX: successful surgical experience with a purified factor IX concentrate. Am J Hematol. 1992 Jul;40(3):210-5. Erken EH. Radiocolloids in the management of hemophilic arthropathy in children and adolescents. Clin Orthop Relat Res. 1991 Mar; (264):129-35. Forbes CD, Barr RD, Reid G, Thomson C, et al. Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease. Br Med J. 1972; 2(5809): 311-3. Simpson E, Lin Y, Stanworth S, et al. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev. 2012 Mar 14;3: CD005011. Scharrer I. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency. Haemophilia. 1999 Jul; 5(4):253-9. Négrier C, Menart C, Attali O, et al. Evaluation of coagulation equilibrium at baseline and during factor VIII and factor IX replacement in haemophiliacs. Blood Coagul Fibrinolysis. 1998 Mar; 9 Suppl 1:S135-41. Shapiro AD, Gilchrist GS, Hoots WK, et al. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost. 1998 Nov; 80(5):773-8. https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/648/687 Núm. 1 , Año 2015 : Enero – Marzo 26 1 22 24 Revista Repertorio de Medicina y Cirugíametadata.only